NR. 1 (II)/2007



Olopatadyna – nowy lek w terapii alergicznych schorzeń narządu wzroku

Olopatadine – The New Medicine in the Treatment of Allergic Ocular Disorders


Anna Groblewska, Janusz Czajkowski, Joanna Kaczmarek

Klinika Okulistyki Instytutu „Centrum Zdrowia Matki Polki” w Łodzi
Kierownik: prof. dr hab. n. med. Janusz Czajkowski

Summary: Allergic eye disease is a common ocular problem which has increased in recent years. Olopatadine is a potent, highly selective, well-tolerated topical antihistamine medicine with powerful conventional mast cell stabilizing properties and a number of other useful additional properties that affect the allergic cascade. Further work is required to completely elucidate it's pharmacological properties and comparison with other anti-allergic medicines.
 
Key words: olopatadine, allergic ocular diseases.



linia-lewa.gif (150 bytes)


Redakcja kwartalnika medycznego "Okulistyka"
Oftal Sp. z o.o.
tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45
03-709 Warszawa ul. Sierakowskiego 13 (Szpital)


Redakcja ored@okulistyka.com.pl